Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Eclinicalmedicine
|
October 10, 2024
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable
Christina Yap, Olalekan Lee Aiyegbusi, Emily Alger, et al.
Trials
|
September 6, 2022
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Sharon B Love, Fay Cafferty, Claire Snowdon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2023
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
Claire N Harrison, Jyoti Nangalia, Rebecca Boucher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR
Emily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck, et al.
JAMA
|
May 17, 2022
Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics Guidelines
Samantha Cruz Rivera, Olalekan Lee Aiyegbusi, Jonathan Ives, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2026
Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastoma
Crescens Tiu, Wing Yau, Diogo Silva, et al.
European Urology Oncology
|
June 26, 2025
PERSEUS1: An Open-label, Investigator-initiated, Single arm, Phase 2 Trial Testing the Efficacy of Pembrolizumab in Patients with Metastatic Castration-resistant Prostate Cancer with Mismatch Repair Deficiency and Other Immune-sensitive Molecular Subtypes
Pasquale Rescigno, Maria Dolores Fenor de la Maza, Holly Tovey, et al.
Eclinicalmedicine
|
January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials
Jan Rekowski, Christina Guo, Olga Solovyeva, et al.
Eclinicalmedicine
|
January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols
Moreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Nature
|
October 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance
Christina Guo, Adam Sharp, Bora Gurel, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Eclinicalmedicine
|
October 10, 2024
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable
Christina Yap, Olalekan Lee Aiyegbusi, Emily Alger, et al.
Trials
|
September 6, 2022
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Sharon B Love, Fay Cafferty, Claire Snowdon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2023
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
Claire N Harrison, Jyoti Nangalia, Rebecca Boucher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR
Emily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck, et al.
JAMA
|
May 17, 2022
Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics Guidelines
Samantha Cruz Rivera, Olalekan Lee Aiyegbusi, Jonathan Ives, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2026
Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastoma
Crescens Tiu, Wing Yau, Diogo Silva, et al.
European Urology Oncology
|
June 26, 2025
PERSEUS1: An Open-label, Investigator-initiated, Single arm, Phase 2 Trial Testing the Efficacy of Pembrolizumab in Patients with Metastatic Castration-resistant Prostate Cancer with Mismatch Repair Deficiency and Other Immune-sensitive Molecular Subtypes
Pasquale Rescigno, Maria Dolores Fenor de la Maza, Holly Tovey, et al.
Eclinicalmedicine
|
January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials
Jan Rekowski, Christina Guo, Olga Solovyeva, et al.
Eclinicalmedicine
|
January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols
Moreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Nature
|
October 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance
Christina Guo, Adam Sharp, Bora Gurel, et al.
Page
of 9